Influence of obesity on plasma lipoproteins, glycaemia and insulinaemia in patients with familial combined hyperlipidaemia

International Journal of Obesity

Volumn 21, Issue 5, 1997, Pages 360-366

  Ascaso, J F ^a   Sales, J ^a   Merchante, A ^a   Real, J ^a   Lorente, R ^a   Martinez Valls, J ^a   Carmena, R ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Familial combined hyperlipidaemia; Hyperinsulinaemia; Obesity

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FAMILIAL HYPERLIPEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULINEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0030891295     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800413     Document Type: Article

References (44)

1. Goldstein JL, Hazzard WR, Schrott G, Bierman EL, Motulsky AG. Hyperlipidemia in Coronary Heart Disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 1973; 52: 1533-1543.
2. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky HG. Hyperlipidemia in Coronary Heart Disease. II. Genetic Análisis of Lipid Levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1544-1568.
3. Hazzard WR, Goldstein JL, Schrott HG, Motulsky AG, Bierman EL. Hyperlipidemia in Coronary Heart Disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction. J Clin Invest 1973; 52: 1569-1577.
4. Nikkila EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart disease. Lancet 1973; i: 954-958.
5. Rose HG, Kranz P, Weinstock M, Juliano J, Haft JI. Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype. Am J Med 1973; 54: 148-160.
6. Glueck CJ, Fallat CR, Buncher R, Tsang R, Steiner P. Familial combined hyperlipoproteinemia: Studies in 91 adults and 95 children from 33 kindreds. Metabolism 1973; 22: 1403-1428.
7. Brunzell JD, Schrott HG, Motulsky AG, Bierman EL. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 1976; 25: 313-320.
8. Genest J Jr. Familial combined hyperlipoproteinemia. Can Med Assoc J 1991; 145: 664.
9. Williams RR, Hopkins PN, Hunt SC, Wu LL, Hasstedt SJ, Lalovel JM, Ask KO, Stults BM, Kvida H. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah. Arch Intern Med 1990; 150: 582-588.
10. Ascaso JF, Serrano S, Martinez-Valls J, Hernandez A, DeLera J, Carmena R. Plasma lipoproteins in familial combined hyperlipidemia: A study of hyperlipidemic and normolipidemic kindreds. Nutr Metab Cardiovasc Dis 1992; 2: 165-169.
11. Brunzell JD, Albers JJ, Chait A, Grundy SM, Grosze KE, Donald GB. Plasma lipoprotein in familial combined hyperlipidemia and monogenic hypertriglyceridemia. J Lipid Res 1983; 24: 147-155.
12. Hokanson JE, Austin MA, Zambon A, Brunzell JD. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arteriosclerosis Thromb 1993; 13: 427-434.
13. Rose HG, Kranz P, Weinstock M, Juliano J, Haft JI. Combined hyperlipoproteinemia. Evidence for a new lipoprotein phenotype. Atherosclerosis 1974; 20: 51-64.
14. Durrington PN. Hyperlipidaemia: Diagnosis and Management, 2nd edn. Butterworth Heinemmann: London, 1995, pp 142-145.
15. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramírez ME, Lalouel JM, Wiliams RR. Apolipoprotein low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Arteriosclerosis 1989; 9: 335-344.
16. Welborn TA, Weame K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154-160.
17. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease; results from two population studies in Finland. Diabetes Care 1979; 2: 131-141.
18. Dicimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980; 19: 205-210.
19. Laws A, King AC, Haskell WL, Reaven GM. Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men. Arteriosclerosis Thromb 1991; 11: 1636-1642.
20. Modan M, Halkin H, Lusky A, Segal P, Fuchs Z, Chetrit A. Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. Arteriosclerosis 1988; 8: 227-236.
21. Ronnemaa T, Laakso M, Pyörälä K, Kallio V, Puukka P. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arteriosclerosis Thromb 1991; 11: 80-90.
22. Brunzell JD, Austin MA, Deeb SS, Hokanson JE, Jarvik GP, Nevin DN, Wijsman E, Zambon A, Motulsky AG. Familial combined hyperlipidemia and genetic risk for atherosclerosis. Atherosclerosis X. Elsevier Science BV: Amsterdam, 1995, pp 624-627.
23. Venkatasan S, Cullen P, Pacy P, Halliday D, Scott J. Stable isotopes show a direct relation between VLDL apo B over-production and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arteriosclerosis Thromb 1993; 13: 1110-1118.
24. Mykkanen L, Kuusisto J, Haffner SM, Pyorala K, Laakso M. Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arteriosclerosis Thromb 1994; 14: 518-526.
25. Selby JV, Austin MA, Newman B, Zhang D, Queensberry CP, Mayer EJ, Krauss RM. LDL subclasses phenotypes and the insulin resistance syndrome in women. Circulation 1993; 88: 381-387.
26. Terry RB, Wood PD, Haskell WL, Stefanick, Krauss RM. Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction in men. J Clin Endocrinol Metab 1989; 68: 408-411.
27. Peins AN, Mueller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest 1986; 78: 1648-1657.
28. DeFronzo RA, Ferranini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
29. National Institutes of Health. Consensus Development Panel on the Health Implications of Obesity. Health implications of obesity. Ann Int Med 1985; 1031: 1073-1077.
30. Kuzcmarski RJ. Prevalence of overweight and weight gain in the United States. Am J Clin Nutr 1992; 55: 495-502.
31. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1979; 20: 470-475.
32. Ter FH, Baarscheer T, Folet JWT. Influence of free glycerol on enzymatic measurement of triglycerides. Clin Chem 1984; 30: 1102-1103.
33. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lip Res 1970; 11: 583-595.
34. Havel RJ, Eder HJ, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-1354.
35. Rosseneau M, Verchemst R, Steinberg KK, Cooper GR. Some considerations of methodology and standardization of apolipoprotein B immunoassays. Clin Chem 1983; 29: 427-433.
36. Diabetes Mellitus Report of a WHO Study Group. Second Report. WHO: Geneve, Technical Report Series 727, 1985, p 99.
37. Trinder P. Enzymatic method for glucose determination. Ann Clin Biochem 1969; 6: 24-27.
38. Berson S, Yallow RS. Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 1959; 38: 1996-2016.
39. Statgraphics Plus 1.0. Statistical Graphic Corporation, 1994.
40. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk for ischemic heart disease. N Engl J Med 1996; 334: 952-957.
41. Castro-Cabezas M, de Bruin TW, de Walk HW, Shoulders CC, Jansen H, Williams-Erkelens D. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest 1993; 92: 160-168.
42. Tzagournis M, Chiles R, Ryan JM, Skillman TG. Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients with coronary heart disease. Circulation 1968; 38: 1156-1163.
43. Kwiterovich PO Jr. Genetic and molecular biology of familial combined hyperlipidemia. Current Opinion in Lipidology 1993; 4: 133-143.
44. Despres JP. Dyslipidemia and obesity. Baillieres Clin Endocrinol Metab 1994; 8: 629-660.